Hassle-Free Site Selection and Study Start-up for Clinical Trials in Canada
It is no secret that Canada’s presence as a key player in the field of pharmaceutical drug development is rapidly…
Do You Believe the Myths About Conducting Clinical Trials in Canada?
Myths exist to explain things we don’t understand, as well as to continue traditions and keep relationships and societies ‘safe’.…
Do Data Entry Issues & Backlog Threaten Your Clinical Trial?
6 Critical Factors for Prevention & Mitigation Collecting clinical data that are accurate, reliable and of high quality is the…
What is Most Important When Conducting Oncology Clinical Research in Canada?
Developing oncology compounds is a constantly evolving process, and with the dramatic rise in costs, and competitive trials, making every…
How Do CRAs Proactively Manage Risk with These Soft Skills?
CRAs with Key Soft Skills Leads to Honest Communication and Better Risk Management at Sites Open communication with sites is…
Daffodils & Cancer Research – what’s the connection?
The daffodil is a symbol of strength, of resilience, of courage and life. It survives our harsh Canadian winters to…
Your Specialized Oncology CRO as Strategic Advisor – Real World Evidence
Optimizing the partnership between Sponsors and CROs can move the relationship from a tactical client/vendor operating model to a more…
What to Look for When Selecting a CRO – Real World Evidence
There is a myriad of factors involved in selecting a CRO. Do CRO team members have the necessary therapeutic expertise?…
2018 in Retrospect – Real World Evidence of Win-Win CRO/Sponsor Relationships
What’s in Store for 2019 and Beyond? The Clinical Trials Market was valued at USD 32,700 million in 2017 and…
7 Tips for Efficient Oncology Study Start-up
7 Tips for efficient study start-up: No.1) Involve Canadian oncologists early on and gather country-specific insight regarding possible enrollment…